enow.com Web Search

  1. Ads

    related to: tecentriq hybreza approval

Search results

  1. Results from the WOW.Com Content Network
  2. Atezolizumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Atezolizumab/hyaluronidase

    The subcutaneous injection of atezolizumab and hyaluronidase was evaluated in IMscin001 (NCT03735121), an open-label, multi-center, international, randomized trial in adults with locally advanced or metastatic non-small cell lung cancer who were not previously exposed to cancer immunotherapy and who had disease progression following treatment with platinum-based chemotherapy. [2]

  3. Atezolizumab - Wikipedia

    en.wikipedia.org/wiki/Atezolizumab

    Atezolizumab, sold under the brand name Tecentriq among others, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma, [9] [11] but discontinued for use in triple-negative breast cancer (TNBC). [12]

  4. Hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Hyaluronidase

    A human recombinant hyaluronidase kit, Hyqvia, was approved for use in the European Union in May 2013, [25] and in the United States in September 2014. [ 26 ] [ 27 ] It is a dual vial unit with one vial of immune globulin infusion 10% (human) and one vial of recombinant human hyaluronidase. [ 12 ]

  5. Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer

    www.aol.com/news/roches-tecentriq-gets-fda...

    Roche (RHHBY) gets an FDA approval of sBLA for Tecentriq in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

  6. FDA approves new type of non-opioid pain medication, 1st of ...

    www.aol.com/fda-approves-type-non-opioid...

    This is the first class of non-opioid pain medication approved to treat moderate to severe acute pain approved by the FDA in more than 20 years. The U.S. Food and Drug Administration (FDA) on ...

  7. Bristol-Myers' Sprycel Gets EC Approval for Label Expansion

    www.aol.com/news/bristol-myers-apos-sprycel-gets...

    Bristol-Myers (BMY) receives EC approval for the label expansion of Sprycel for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in patients aged one to 18 years.

  8. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    The US Food and Drug Administration (FDA) approved it in March 2017, for the treatment of Merkel-cell carcinoma, [85] an aggressive type of skin cancer. The EMA approved it in September 2017, for the same indication. [87] This is the first FDA-approved treatment for metastatic Merkel-cell carcinoma, a rare, aggressive form of skin cancer. [85]

  9. AOL

    search.aol.com

    The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.

  1. Ads

    related to: tecentriq hybreza approval